GHK-Cu and skin claims: what the evidence supports

A recent TikTok video by creator Olympia Anley, captioned “You know the drill👀 #biohacking #longevity,” shows a familiar scene: a vial of peptide powder, a syringe, and a knowing nod to the audience. The implication is clear—this peptide is a staple for anyone serious about longevity. While the clip doesn’t name the compound, the context and hashtags point toward GHK-Cu, a copper-binding peptide widely discussed in biohacking circles for its purported skin-rejuvenating and systemic anti-aging effects.

What the clip is claiming

The video’s message is essentially: “This peptide is a must-have for longevity.” It leans on the viewer’s prior knowledge—the “drill” being the daily or weekly injection routine. The claim is not explicit, but the subtext is that GHK-Cu is a proven anti-aging intervention with benefits that extend beyond skin deep. The casual tone suggests that using it is as routine as brushing your teeth, and that the science is settled.

What the research neighborhood actually covers

GHK-Cu is one of the most studied copper peptides. The peer-reviewed literature, spanning decades, focuses heavily on skin health: it promotes collagen synthesis, supports wound healing, and has antioxidant properties. In cell culture and some animal models, GHK-Cu has been shown to modulate gene expression in ways that could be relevant to tissue repair and inflammation. There is also a smaller body of research exploring its potential in hair growth and even cognitive function, but these are far less established.

Importantly, the research that exists is predominantly in vitro (test tube) or in vivo in animals. Human clinical trials are limited, and most that do exist are small, short-term, and focused on topical application for skin conditions—not systemic injection for longevity. The “longevity” angle is largely extrapolated from mechanistic studies, not from direct evidence that GHK-Cu extends lifespan or delays aging in humans.

Limits, missing context, and what a 15-second clip cannot show

A 15-second TikTok clip cannot convey the nuance of the research. It doesn’t mention that GHK-Cu’s effects are dose-dependent and that the optimal dose for skin health is not necessarily the same as for systemic effects. It doesn’t address the fact that most longevity claims are based on animal models or theoretical mechanisms, not human outcomes. The clip also omits the practical realities: GHK-Cu is typically injected subcutaneously, which requires sterile technique, proper reconstitution, and an understanding of potential side effects like injection-site reactions or copper toxicity if used excessively.

Furthermore, the video’s framing—showing a vial and syringe—implies that the peptide is being used for systemic effects, which is a leap from the topical skin research that dominates the literature. The viewer is left with the impression that “everyone is doing it,” but the reality is that GHK-Cu is not a universally accepted anti-aging therapy; it’s a research compound with promising but incomplete evidence.

How this maps to named research compounds

GHK-Cu is the compound most directly relevant to the clip’s longevity theme. In the research-use peptide catalog, GHK-Cu is listed as a standalone peptide. It is often paired with other peptides in blends, but the clip’s focus on a single vial suggests GHK-Cu alone. For researchers, GHK-Cu is a valuable tool for studying copper-dependent pathways, extracellular matrix remodeling, and wound healing. However, the catalog also includes other peptides with more robust longevity-related evidence, such as NAD+ (a coenzyme involved in cellular energy) and SS-31 (a mitochondrial-targeted peptide). The clip’s implication that GHK-Cu is the go-to longevity peptide overlooks these alternatives, which have different mechanisms and research trajectories.

Research-use caveat

All peptides in the catalog are intended for research use only, not for human consumption. The claims made in social media clips are not a substitute for rigorous scientific inquiry. Researchers should consult primary literature, design controlled experiments, and adhere to ethical guidelines. The information in this article is for educational purposes and does not constitute medical advice.